Palatin Technologies, Inc. (PTN)
5.52
-0.47
(-7.85%)
USD |
NASDAQ |
Oct 20, 16:00
5.60
+0.08
(+1.45%)
After-Hours: 20:00
Palatin Technologies Enterprise Value : 2.554M for Oct. 20, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 20, 2026 | 2.554M |
| October 19, 2026 | 3.390M |
| October 16, 2026 | 3.443M |
| October 15, 2026 | 4.280M |
| October 14, 2026 | 5.934M |
| October 13, 2026 | 7.304M |
| October 12, 2026 | 7.945M |
| October 09, 2026 | 8.034M |
| October 08, 2026 | 8.763M |
| October 07, 2026 | 9.671M |
| October 06, 2026 | 9.475M |
| October 05, 2026 | 9.600M |
| October 02, 2026 | 9.333M |
| October 01, 2026 | 8.852M |
| September 30, 2026 | 8.514M |
| September 29, 2026 | 8.959M |
| September 28, 2026 | 9.778M |
| September 25, 2026 | 10.69M |
| September 24, 2026 | 10.22M |
| September 23, 2026 | 11.01M |
| September 22, 2026 | 11.01M |
| September 21, 2026 | 10.92M |
| September 18, 2026 | 12.06M |
| September 17, 2026 | 11.29M |
| September 16, 2026 | 9.564M |
| Date | Value |
|---|---|
| September 15, 2026 | 12.20M |
| September 14, 2026 | 16.50M |
| September 11, 2026 | 13.73M |
| September 10, 2026 | 14.12M |
| September 09, 2026 | 14.67M |
| September 08, 2026 | 15.29M |
| September 04, 2026 | 15.33M |
| September 03, 2026 | 16.00M |
| September 02, 2026 | 15.58M |
| September 01, 2026 | 13.26M |
| August 31, 2026 | 10.51M |
| August 28, 2026 | 11.38M |
| August 27, 2026 | 11.40M |
| August 26, 2026 | 11.36M |
| August 25, 2026 | 11.18M |
| August 24, 2026 | 10.81M |
| August 21, 2026 | 9.973M |
| August 20, 2026 | 10.88M |
| August 19, 2026 | 10.85M |
| August 18, 2026 | 11.43M |
| August 17, 2026 | 10.44M |
| August 14, 2026 | 9.386M |
| August 13, 2026 | 10.52M |
| August 12, 2026 | 9.582M |
| August 11, 2026 | 5.916M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.636B |
| Alnylam Pharmaceuticals, Inc. | 30.53B |
| Anika Therapeutics, Inc. | 260.39M |
| Savara, Inc. | 835.07M |
| Vericel Corp. | 2.009B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.359M |
| Revenue (Quarterly) | 0.3008M |
| Total Expenses (Quarterly) | 4.659M |
| EPS Diluted (Quarterly) | -1.112 |
| Gross Profit Margin (Quarterly) | 94.35% |
| Profit Margin (Quarterly) | -1.45K% |
| Earnings Yield | -1.45% |
| Normalized Earnings Yield | -1.448 |